Overview

Pentoxifylline in Treatment of Patients With Nonalcoholic Steatohepatitis

Status:
Active, not recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
The aim of the present study is to evaluate the efficacy and safety of pentoxifylline in the treatment of non-alcoholic steatohepatitis patients.
Phase:
Phase 3
Details
Lead Sponsor:
Al-Azhar University
Treatments:
Pentoxifylline